MACA Ltd
ASX:MLD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
MACA Ltd
Cash Equivalents
MACA Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MACA Ltd
ASX:MLD
|
Cash Equivalents
AU$91.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
BHP Group Ltd
ASX:BHP
|
Cash Equivalents
$10.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
South32 Ltd
ASX:S32
|
Cash Equivalents
$702m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Rio Tinto Ltd
ASX:RIO
|
Cash Equivalents
$9.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Pilbara Minerals Ltd
ASX:PLS
|
Cash Equivalents
AU$3B
|
CAGR 3-Years
335%
|
CAGR 5-Years
91%
|
CAGR 10-Years
N/A
|
|
Mineral Resources Ltd
ASX:MIN
|
Cash Equivalents
AU$1.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
22%
|
See Also
What is MACA Ltd's Cash Equivalents?
Cash Equivalents
91.6m
AUD
Based on the financial report for Jun 30, 2022, MACA Ltd's Cash Equivalents amounts to 91.6m AUD.
What is MACA Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
9%
Over the last year, the Cash Equivalents growth was -25%. The average annual Cash Equivalents growth rates for MACA Ltd have been 16% over the past three years , -4% over the past five years , and 9% over the past ten years .